Delivery Order SPE2DB22D2211-SPE2DB24FPDE7

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,925,986 units of Cyclosporine 0.05% eye emulsion in 30-count packages, with a ceiling value of $1,083.84. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,758.35 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, with an ultimate completion date of November 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,515.64 firm fixed price contract is for the supply of cyclosporine 0.05% eye emulsion in 30-count packages. The contract has an ultimate completion date of August 20, 2024 and was awarded on August 19, 2024. No set-aside was used for this award. Amerisourcebergen is a major pharmaceutical distributor that holds several...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% eye emulsion, a medication used to treat certain eye conditions. The award has a ceiling value of $2,972.19 and an ultimate completion date of April 19, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,324.86 firm fixed price contract is for the supply of Cyclosporine 0.05% eye emulsion, a pharmaceutical product. The contract has an ultimate completion date of August 27, 2024. Amerisourcebergen is one of the largest pharmaceutical distributors in the United States and has been awarded numerous federal contracts by various defense and civilian agencies...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a Firm Fixed Price Delivery Order. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion 30-count, a specialty pharmaceutical product, with an ultimate completion date of April 15, 2024 and a ceiling value of $1,908.15. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,476.44, is for the delivery of Cyclosporine 0.05% eye emulsion in 30-count packages. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on September 20, 2023. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cyclosporine 0.05% eye emulsion, a critical ophthalmic medication, to support military treatment facilities and other government healthcare programs. The contract has a firm fixed price of $2,991.65 and runs through September 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The $2,181.63 contract has an ultimate completion date of December 5, 2022 and is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceuticals and medical supplies to support military...
This federal contract award is for the delivery order SPE2DX24F8QR8 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product Cyclosporine 0.05% eye emulsion. The contract has a ceiling value of $4,299.06 and is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor. The ultimate completion date for this order is June 26, 2024. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FPDE7
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,441,778 units of Cyclosporine 0.05% Eye Emulsion in 60-count packages, with a ceiling value of $2,544.21 and an ultimate completion date of August 14, 2024. This award is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and civilian agencies, including a $999,999,999 IDC with the DLA Troop Support Medical through December 2025 for a wide range of medical commodities. The company's extensive federal contracting activities focus on supplying critical pharmaceutical products and medical supplies to support military treatment facilities, veterans' hospitals, and other government healthcare programs.

Generated 11/12/24, 9:13 AM